Britain’s largest private medical imaging company, Scan.com, has secured $220 million in new funding as it aims to expand its presence in the United States medical imaging market. The London-based company plans to use the capital to accelerate its growth in the US, where it already generates the majority of its revenue and employs around 80 percent of its workforce.
The fundraising comprises a $90 million equity round led by French investment firm Noteus Partners, with participation from investors including Aviva and Concord Health Partners. Additionally, the company secured $130 million in debt financing from VerisFi Capital and Atempo Growth. Scan.com’s recent capital raise follows earlier funding rounds totaling just over $57 million.
The US medical imaging market is estimated to be worth more than $100 billion and is expected to grow to approximately $121 billion by 2033, according to projections from Grand View Research. Scan.com’s co-founder and chief executive, Charlie Bullock, highlighted the fragmented nature of the US imaging market, noting that despite approximately 600 million imaging scans performed annually, there is no centralized national infrastructure comparable to that which exists in laboratory services.
“We are a fraction of 1 percent in market penetration,” Bullock said, adding that the company’s ambition is to become the largest diagnostic imaging provider in the US. While he acknowledged Scan.com is still in the early stages of this goal, he expressed confidence in the company’s trajectory. Despite the focus on US growth, Bullock emphasized that the company has no plans to relocate its headquarters from the UK.
The company, founded in 2021 by Bullock alongside Oliver Knight, Joe Daniels, osteopath Jasper Nissim, and consultant radiologist Khalid Latief, initially launched in the UK to address issues such as limited access to diagnostic imaging, lack of price transparency, and long National Health Service (NHS) waiting times. By leveraging spare capacity in private imaging centers and hospitals, Scan.com offers a digital platform for booking scans, managing referrals, and sharing results. The business generated $85 million in revenue last year.
The funding round coincides with Scan.com’s preparation for meetings with officials at the London Stock Exchange regarding a potential initial public offering (IPO). However, a definitive decision on where to list the company has not yet been made.
The fundraising also occurs amid broader concerns about the UK’s ability to support scale-up capital for high-growth startups, prompting a consortium of UK pension providers to explore the creation of a "UK Scale-up Fund" with more than £1 billion in assets. Ant Barker, director of venture capital at Aviva Investors, emphasized the increasing desire among pension funds to invest in unlisted companies that develop emerging technologies and generate social value. He described Scan.com as one of the fastest-growing companies in Aviva’s venture capital portfolio, with strong potential for delivering long-term returns for UK savers and institutional investors.
